- Home
- PMCB vs JZXN Comparison
PMCB vs JZXN Comparison
Compare PMCB & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- JZXN
- Stock Information
- Founded
- PMCB 1996
- JZXN 2017
- Country
- PMCB United States
- JZXN China
- Employees
- PMCB N/A
- JZXN N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- PMCB Health Care
- JZXN Consumer Discretionary
- Exchange
- PMCB Nasdaq
- JZXN Nasdaq
- Market Cap
- PMCB 10.9M
- JZXN 14.6M
- IPO Year
- PMCB N/A
- JZXN 2021
- Fundamental
- Price
- PMCB $1.55
- JZXN $1.39
- Analyst Decision
- PMCB
- JZXN
- Analyst Count
- PMCB 0
- JZXN 0
- Target Price
- PMCB N/A
- JZXN N/A
- AVG Volume (30 Days)
- PMCB 13.1K
- JZXN 788.7K
- Earning Date
- PMCB 12-13-2024
- JZXN 01-10-2025
- Dividend Yield
- PMCB N/A
- JZXN N/A
- EPS Growth
- PMCB N/A
- JZXN N/A
- EPS
- PMCB 0.74
- JZXN N/A
- Revenue
- PMCB N/A
- JZXN $7,597,423.00
- Revenue This Year
- PMCB N/A
- JZXN N/A
- Revenue Next Year
- PMCB N/A
- JZXN N/A
- P/E Ratio
- PMCB $2.11
- JZXN N/A
- Revenue Growth
- PMCB N/A
- JZXN 81.94
- 52 Week Low
- PMCB $1.39
- JZXN $1.00
- 52 Week High
- PMCB $2.58
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- PMCB 40.08
- JZXN 48.30
- Support Level
- PMCB $1.60
- JZXN $1.25
- Resistance Level
- PMCB $1.62
- JZXN $1.83
- Average True Range (ATR)
- PMCB 0.08
- JZXN 0.33
- MACD
- PMCB -0.01
- JZXN -0.01
- Stochastic Oscillator
- PMCB 7.84
- JZXN 32.50
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.